Survival studies of 51Cr Ch(a+) red blood cells in a patient with anti-Cha, and massive transfusion of incompatible blood.
Survival studies of 51Cr, Ch(a+) red blood cells in a patient with anti-Cha, showed normal survival time in the observation period of 6 days. Successive massive transfusion of Ch(a+) blood was performed without any complication. A very strong secondary immune response to the Ch antigen was observed.
D000368:Aged; D000906:Antibodies / Q000276:immunology*; D001789:Blood Group Antigens; D001787:Blood Group Incompatibility / Q000209:etiology*; D002860:Chromium Radioisotopes; D003181:Complement C4 / Q000378:metabolism; D004905:Erythrocyte Aging; D006801:Humans; D008297:Male; D013997:Time Factors
D000906:Antibodies; D001789:Blood Group Antigens; D002860:Chromium Radioisotopes; D003181:Complement C4